[{"data":1,"prerenderedAt":63},["ShallowReactive",2],{"q-nurse-112-3-medical-surgical-032":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":32,"lastmod":62},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":10},"nurse-112-3-內外科護理學-032","nurse-112-3-medical-surgical-032",112,3,32,"有關器官移植後的護理指導，下列何者錯誤？",{"A":14,"B":15,"C":16,"D":17},"鼓勵運動多曬太陽，以增進身心健康","避免出入公共場所，外出戴口罩","服藥出現藥物副作用，不可自行停藥","需要暫時避孕，若準備懷孕應停藥至少 2 至 3 週","A",null,[],"本題考點在於器官移植後長期免疫抑制下的自我照護重點。本題為反向題,錯誤敘述為A;移植後病人長期服用免疫抑制劑,皮膚癌風險升高且免疫力低下,鼓勵多曬太陽並不適當,故A為錯誤選項。B避免出入公共場所、外出戴口罩可降低感染機會,正確。C出現藥物副作用不可自行停藥,以免誘發排斥,正確。D需暫時避孕、準備懷孕前應依醫囑調整藥物,正確。","免疫抑制劑(如calcineurin抑制劑、類固醇)使病人處於「感染」與「惡性腫瘤」雙重風險,皮膚癌尤其常見,故衛教強調防曬、防感染、規律回診監測藥物濃度。停藥或漏藥是排斥的重要誘因,需就醫評估而非自行增減。",[24,26,29],{"term":25,"count":10},"免疫抑制劑",{"term":27,"count":28},"感染與皮膚癌風險",2,{"term":30,"count":31},"器官移植後照護",1,[33,37,42,47,52,57],{"webId":34,"stem":35,"number":36,"year":9,"session":10},"nurse-112-3-medical-surgical-033","有關全身性紅斑性狼瘡（SLE）病人的診斷檢查結果，下列何者正確？",33,{"webId":38,"stem":39,"number":40,"year":41,"session":28},"nurse-113-2-medical-surgical-029","有關全身性紅斑性狼瘡之醫療處置之敘述，下列何者錯誤？",29,113,{"webId":43,"stem":44,"number":45,"year":46,"session":31},"nurse-114-1-medical-surgical-023","中樞神經系統癌症病人，若選用難以通過血腦障壁之化學治療時，下列何者為最適切之給藥途徑？ ①Port-A   ②Ommaya reservoir   ③Hickman catheter   ④intrathecal injection",23,114,{"webId":48,"stem":49,"number":50,"year":51,"session":28},"nurse-115-2-medical-surgical-021","有關癌細胞特性的敘述，下列何者正確？",21,115,{"webId":53,"stem":54,"number":55,"year":56,"session":31},"nurse-107-1-medical-surgical-015","有關肝癌病人接受動脈栓塞療法（Transcatheter Arterial Embolization, TAE）之敘述，下列何者正確？",15,107,{"webId":58,"stem":59,"number":60,"year":61,"session":31},"nurse-108-1-medical-surgical-049","有關全身性紅斑性狼瘡的護理措施，下列何者錯誤？",49,108,"2026-09-04",1788510745059]